Xbrane Biopharma AB (XBRANE) — Tangible Net Worth Ratio
Xbrane Biopharma AB (XBRANE) has a Tangible Net Worth Ratio of 41.6% as of June 2026. This metric is calculated by deducting intangible assets (Skr314.82 Million) from net assets (Skr538.85 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore XBRANE net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Xbrane Biopharma AB Tangible Net Worth Ratio (2012–2025)
This chart shows how Xbrane Biopharma AB's Tangible Net Worth Ratio has changed across 14 annual periods from 2012 to 2025. As of June 2026, the ratio stands at 41.6%, reflecting net assets of Skr538.85 Million with intangible assets of Skr314.82 Million SEK. For live market cap and overall valuation, see Xbrane Biopharma AB market capitalisation.
Annual Tangible Net Worth Ratio for Xbrane Biopharma AB (2012–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Xbrane Biopharma AB from 2012 to 2025, covering 14 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore XBRANE capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (SEK) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 47.1% | Skr560.65 Million | Skr296.46 Million | Skr671.62 Million | ▲ +27.5 pp |
| 2024 | 19.6% | Skr208.54 Million | Skr167.69 Million | Skr842.43 Million | ▼ -22.2 pp |
| 2023 | 41.8% | Skr171.34 Million | Skr99.67 Million | Skr653.51 Million | ▼ -34.2 pp |
| 2022 | 76.0% | Skr424.89 Million | Skr102.00 Million | Skr690.51 Million | ▼ -12.5 pp |
| 2021 | 88.5% | Skr431.74 Million | Skr49.67 Million | Skr688.43 Million | ▼ -9.9 pp |
| 2020 | 98.4% | Skr257.71 Million | Skr4.08 Million | Skr463.76 Million | ▲ +1.2 pp |
| 2019 | 97.3% | Skr184.32 Million | Skr5.05 Million | Skr338.94 Million | ▲ +4.2 pp |
| 2018 | 93.1% | Skr83.07 Million | Skr5.77 Million | Skr252.88 Million | ▲ +0.2 pp |
| 2017 | 92.9% | Skr88.41 Million | Skr6.30 Million | Skr110.96 Million | ▲ +0.8 pp |
| 2016 | 92.1% | Skr107.30 Million | Skr8.46 Million | Skr118.11 Million | ▲ +4.8 pp |
| 2015 | 87.3% | Skr47.51 Million | Skr6.03 Million | Skr75.33 Million | ▼ -12.7 pp |
| 2014 | 100.0% | Skr6.30 Million | Skr0.00 | Skr6.69 Million | ▲ +0.0 pp |
| 2013 | 100.0% | Skr8.69 Million | Skr0.00 | Skr9.20 Million | ▲ +0.0 pp |
| 2012 | 100.0% | Skr88.11K | Skr0.00 | Skr657.01K | — |